Holdings
Avoro Capital Advisors LLC
As of Sep 30, 2026, Avoro Capital Advisors LLC reported 25 positions worth US$8.22B. Largest: United Therapeutics Corporation, Krystal Biotech, Inc. and argenx SE. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| United Therapeutics Corporation | 2.76M | US$1.49B | −22,222 | Sep 30, 2026 |
| Krystal Biotech, Inc. | 2.89M | US$961M | no change | Sep 30, 2026 |
| argenx SE | 1M | US$959M | no change | Sep 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 1.83M | US$924M | no change | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 7.47M | US$836M | no change | Sep 30, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 11M | US$720M | −356K | Sep 30, 2026 |
| Revolution Medicines, Inc. | 2.15M | US$440M | −152K | Sep 30, 2026 |
| Cytokinetics, Incorporated | 4.9M | US$323M | −99,999 | Sep 30, 2026 |
| Definium Therapeutics, Inc. | 7.05M | US$268M | −139K | Sep 30, 2026 |
| Structure Therapeutics, Inc. | 6.56M | US$205M | new | Sep 30, 2026 |